Affibody signs distribution agreement with Funakoshi


Affibody AB and Funakoshi Co., Ltd., announced an agreement in which Funakoshi will promote and distribute products from Affibody's portfolio of biotechnology research reagents to the Japanese market.

"We are delighted with this distribution agreement, Affibody's exciting new class of affinity ligands complement our range of top quality products and will enable us to meet the high demand for research reagents in Japan" said Dr. Ryoya Funakoshi, President & CEO of Funakoshi Co., Ltd. Torben Jørgensen, CEO of Affibody, added: "Funakoshi has an excellent reputation on the Japanese market and we appreciate that Funakoshi Co., Ltd. operates as our distributor as it opens up an important sales channel for Affibody. We look forward to a fruitful and long-lasting cooperation".

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy